Application 212871
- Type
- ANDA
- Sponsor
- ASPEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212871-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212871-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212871-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Piramal Critical Care Inc | 83d70378-011b-4ce3-e053-2991aa0a22be | 2026-06-23 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Cardinal Health 107, LLC | 65688bed-0d70-4b51-8301-1948b1deade1 | 2026-06-02 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | REMEDYREPACK INC. | 220cd5f5-3d71-4fdb-9943-7468799c179f | 2026-06-02 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Golden State Medical Supply, Inc. | ec15e70c-8473-469a-9f07-ea668783fa07 | 2026-05-27 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02541cfd-b209-49b9-a73f-13ef18dce06d | 2026-05-20 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Par Health USA, LLC | ff65c5d3-7ba9-4315-a884-199151eb45a5 | 2026-05-14 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 098c7654-a352-47ee-bf23-6a81f8601266 | 2026-05-05 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Atlantic Biologicals Corp. | 50b493d7-8e3b-e459-e063-6394a90addbc | 2026-04-30 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Gland Pharma Limited | d670bd26-8a44-44be-90e1-107d4c380233 | 2026-04-28 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | 741355f5-b695-41bb-a065-4abc687312b2 | 2026-04-28 | Warnings, Adverse reactions | glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Sagent Pharmaceuticals | 55930f87-8964-43b1-b790-c1e6dd2602d2 | 2026-04-20 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 21c7d201-c0b8-4f16-be4a-681d0b22791e | 2026-04-03 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Sandoz Inc | cb1ae370-ec4f-4114-9860-8f736f72b545 | 2026-04-01 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | REMEDYREPACK INC. | a338ef22-c243-4075-b02d-bcd5b590104a | 2026-03-26 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | REMEDYREPACK INC. | fafea739-87d0-4421-833f-eb066791504c | 2026-03-26 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Lifestar Pharma LLC | 0f4a4b94-71e0-49ed-8f1e-c760e4dd3137 | 2026-03-25 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Major Pharmaceuticals | 6e5bfe6d-d321-4f0f-86e2-457d8fd10a6a | 2026-03-19 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| glycopyrrolate | GLYCOPYRROLATE | Bionpharma Inc. | 512d3f1e-c35c-87c2-e063-6394a90a8de0 | 2026-03-05 | Warnings, Adverse reactions | glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | NCS HealthCare of KY, LLC dba Vangard Labs | 5ed930b7-a36e-4bf8-b1d1-dad238d3dd18 | 2026-02-25 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 10ea264f-e157-4e13-9d79-b4228daf359d | 2026-02-17 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25021-789 | Glycopyrrolate | Glycopyrrolate | Sagent Pharmaceuticals | ANDA | Current |
| 25021-789 | Glycopyrrolate | Glycopyrrolate | Sagent Pharmaceuticals | ANDA | Current |
| 25021-789 | Glycopyrrolate | Glycopyrrolate | Sagent Pharmaceuticals | ANDA | Current |